Summary Information:
Osmotica Pharmaceuticals plc Ordinary Shares
NASDAQ:OSMT


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Osmotica Pharmaceuticals plc Ordinary Shares
Exchange: NASDAQ
Symbol: OSMT
SEC CIK: 0001739426
Phone: 9088091300
400 CROSSING BOULEVARD
BRIDGEWATER NJ 08807

CEO:
Price when page updated: 1.13 Date: 2022-01-15
Company Website:
www.osmotica.com

_Description: Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. The company has a diverse portfolio consisting of promoted and non-promoted products, several of which incorporate Osmotica’s proprietary Osmodex® drug delivery system. RVL Pharmaceuticals, Inc. is the Company’s ophthalmic subsidiary supporting Upneeq®. Vertical Pharmaceuticals, LLC represents the Company’s diversified branded portfolio and Trigen Laboratories, LLC represents the Company’s non-promoted products, including complex generic formulations. Osmotica has operations in the United States, Argentina, and Hungary.

IPO YEAR:
2018
Sector:
Health Care
Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
94117509.00
Beta:
0.603784904318759
52 Week High:
5.98
52 Week Low:
0.9801
52 Week Change:
-0.8091993185689949
Short Interest:

Short Date:

Shares Outstanding:
83289831
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
N/A
Float:
0
return on Equity:
4.30%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
N/A
ttmEPS:
0
Revenue:
N/A
Gross Profit:

Cash:

Debt:

Institution Percent:
74.80%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
9.00%
Return on Assets:
4.00%
Return on Capital:

Profit Margin:
-
Price to Sales:
-
Price To Book:
1.30
Short Ratio:
0.16
PE Ratio:
0
Employees:
302
1Y Guesstimate
4.540:4.0:4




__The following are links to various summary and news pages for
__Osmotica Pharmaceuticals plc Ordinary Shares [ OSMT ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2022-01-15